BSE   18 Jun 13 | 12:00 AM 444.15 -1.8 (-0.4%) Mkt Price (Rs)   Chg Rs (Chg %) Code: 524816 Face Value: 10

NSE   18 Jun 13 | 12:00 AM 443.30 -2.6 (-0.58%) Mkt Price (Rs)   Chg Rs (Chg %) Code: NATCOPHARM

Performance 1 Week : Rs 428.65 (3.62%) 1 Month : Rs 433.50 (2.46%) 1 Year : Rs 373.60 (18.88%)

Smart Charts | Add to my portfolio | Derivative

News 03 Apr 13 00:44 Domestic firms rejoicing on Glivec verdict 01 Apr 13 11:34 Natco, Cipla up after Supreme Court dismisses Novartis petition 05 Mar 13 09:24 Natco Pharma rallies on winning cancer drug case 19 Dec 12 15:42 Natco recives USFDA approval for anti-ulcer drug 15:17 Natco Pharma rallies on USFDA nod for Lansoprazole 29 Nov 12 14:43 Natco Pharma hits record high after IPAB dismisses AstraZeneca drug appeal

Stock Summary

Shareholding Pattern Promoters 56.67 % Mutual Funds / UTI 10.05 % FI/Bank 0.01 % Insurance 0.00 % Others 0.00 % Govt 0.00 % FII 9.23 % Non-Institutions 24.04 % Depository Receipts 0.00 % Total 100.00 %

Key Financials (Rs cr) Mar 2013 Mar 2012 YOY Operating Income 170.77 152.05 12.31 Total Expenses 136.55 126.22 8.18 Operating Profit 34.22 25.83 32.48 Other Income 1.84 0.74 148.65 PBDIT 36.06 26.57 35.72 PBT 21.58 18.70 15.40 Adjusted Net Profit 12.03 12.65 -4.90

Peer Group Company Last (Rs) Chg (%) Mkt Cap (Rs cr) Novartis India 501.40 2.66 1,603 Unichem Labs. 166.90 0.33 1,510 Merck 645.10 -0.99 1,071 Claris Lifescien 149.00 -0.23 951 Panacea Biotec 124.70 15.73 764

Funds Owning this Stock Scheme Name Value (Rs cr) ICICI Pru Discovery Fund - Inst Option - 1 (G) 46.15 ICICI Pru Discovery Fund (G) 44.45 ICICI Pru Discovery Fund - Direct (G) 44.38 L&T Tax Advantage Fund (G) 24.26 L&T Tax Advantage Fund - Direct (G) 23.25

Announcements

Research Reports Date Broker Action Price (Rs) Report 17/08 Anand Rathi Buy 356